EDGAR Filing Documents for 0001144204-13-023539

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001144204-13-023539

Filing Date

2013-04-24

Accepted

2013-04-24 11:44:50

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PROSPECTUS SUPPLEMENT	v342361_424b5.htm	424B5	306673
2	GRAPHIC	image_001.jpg	GRAPHIC	7080
3	GRAPHIC	tlogo1.jpg	GRAPHIC	32906
	Complete submission text file	0001144204-13-023539.txt		363135

Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017

Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)